Suchergebnisse - "Graf, Tilmann"

PubPharm (4)

1

Immediate high-dose intravenous immunoglobulins followed by direct thrombin-inhibitor treatment is crucial for survival in Sars-Covid-19-adenoviral vector vaccine-induced immune thrombotic thrombocytopenia VITT with cerebral sinus venous and portal vein thrombosis

enthalten in: Journal of neurology | 2021

von Graf, T. | Thiele, T. | Klingebiel, R. | +3

2

Immediate high-dose intravenous immunoglobulins followed by direct thrombin-inhibitor treatment is crucial for survival in Sars-Covid-19-adenoviral vector vaccine-induced immune thrombotic thrombocytopenia VITT with cerebral sinus venous and portal vein thrombosis

enthalten in: Journal of neurology | 2021

von Graf, T. | Thiele, T. | Klingebiel, R. | +3

3

Immediate high-dose intravenous immunoglobulins followed by direct thrombin-inhibitor treatment is crucial for survival in Sars-Covid-19-adenoviral vector vaccine-induced immune thrombotic thrombocytopenia VITT with cerebral sinus venous and portal vein thrombosis

enthalten in: Journal of neurology | 2021

von Graf, T. | Thiele, T. | Klingebiel, R. | +3

4

Immediate high-dose intravenous immunoglobulins followed by direct thrombin-inhibitor treatment is crucial for survival in Sars-Covid-19-adenoviral vector vaccine-induced immune thrombotic thrombocytopenia VITT with cerebral sinus venous and portal vein thrombosis

enthalten in: Journal of neurology | 2021

von Graf, T. | Thiele, T. | Klingebiel, R. | +3

1
[1]